News
Eli Lilly's Mounjaro and Zepbound drove Q2 2025 revenue up 38% and EPS up 92% YoY. Read why LLY stock's recent 20% pullback ...
Independent.ie on MSN6h
Pharma companies warned Government over competitiveness before Trump’s tariff war began
Major pharmaceutical companies raised concerns about Ireland’s competitiveness, ahead of Donald Trump’s opening shots in early April which began the tariff war with the EU. Correspondence released ...
Viking Therapeutics' dual-formulation obesity program could capture the most profitable patient segment starting in 2027. At 29 times forward earnings, Lilly stock assumes flawless execution with no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback